Researchers say hydroxychloroquine could still prevent COVID-19
Scientists from the University of Oxford say the drug is being ‘discarded prematurely’
Read More
Tag: hydroxychloroquine
Novartis pulls plug on hydroxychloroquine trial
Study assessing its potential for COVID-19 discontinued due to feasibility of recruitment
Read More
MHRA suspends COVID-19 hydroxychloroquine trials
The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised with COVID-19
Read More
The Lancet retracts study linking hydroxychloroquine with deaths
The study linked the drug with higher death rates in patients with COVID-19
Read More
Hydroxychloroquine fails as postexposure prophylaxis for COVID-19
However, the trial did have limitations, researchers note
Read More
First UK healthcare worker to enrol in COVID-19 prevention trial
Over 130 UK frontline healthcare workers have lost their lives during the pandemic
Read More
Novartis to test hydroxychloroquine for coronavirus
The study follows early preclinical and clinical evidence that hydroxychloroquine may be beneficial in the fight against the virus
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
